Yoshihama T

No ORCID on file · 2 papers in corpus · active 2024-2025
2025
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.
Cancer research communications ·doi:10.1158/2767-9764.crc-25-0024

There are currently no effective treatments available for clear cell ovarian cancer (CCC). In this study, we aimed to identify effective drugs for CCC through high-throughput drug screening (HTDS) using ovarian cancer organoids and determin…

2024
A rare case of synchronous bilateral ovarian cancer with combined clear cell and mucinous carcinomas and brain metastases.
International cancer conference journal ·doi:10.1007/s13691-024-00686-2

Although ovarian cancer is generally unilateral, a few cases of bilateral ovarian cancer have been reported, most of which originate from metastases of unilateral ovarian cancer. However, synchronous primary bilateral ovarian cancer (SBOC),…